Stay updated on Pembrolizumab SubQ vs IV in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision history updated with a new Revision v3.5.0 and removal of Revision v3.4.3.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision v3.4.3 was added to the history, replacing the previous v3.4.2.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.2 was added. The previous notices about government funding and operating status were removed.SummaryDifference0.6%

- Check60 days agoChange DetectedAdded a government funding status notice and the latest site revision tag (v3.4.1); no trial data or record content was changed.SummaryDifference0.6%

- Check68 days agoChange DetectedUI updates include a glossary toggle, green highlights for additions, red highlights for deletions, and a new revision label (Revision: v3.4.0) on the history page, with the 'No FEAR Act data' note removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check82 days agoChange DetectedThe header revision label changed from v3.3.3 to v3.3.4. This is a site version update and does not modify study data or history entries.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab SubQ vs IV in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.